Active Surveillance of Prostate Cancer with Yushen Qian, MD

Explore a comprehensive lecture on prostate cancer diagnosis and management, delivered by Stanford Health Care radiation oncologist Dr. Yushen Qian. Gain insights into risk factors, cancer risk assessment, age-related PSA levels, prostate biopsy procedures, Gleason scoring, and cancer staging. Understand the distinctions between Watchful Waiting and Active Surveillance approaches, and learn when treatment interventions may be necessary. Delve into topics such as prostate cancer statistics, screening benefits and risks, shared decision-making processes, risk classification, survival rates, and various treatment options including definitive therapy and radiation therapy. The lecture also covers the UK Protect Trial findings and addresses questions on biomarker testing, diet's role in prostate cancer, and the continued relevance of active surveillance in prostate cancer management.

Introduction
Prostate cancer statistics
Prostate cancer without screening
What is PSA
Shared Decision Making Process
Benefits vs Harms
When to Start Screening
Diagnosis
Risk Groups
T Stage
Gleason Score
Risk Classification
Survival
Treatment
Definitive Therapy
UK Protect Trial
Conclusion
Questions
Gleason 4 vs Gleason 3
Role of biomarker testing
Active surveillance vs watchful waiting
Diet and prostate cancer
Would you still recommend active surveillance
PSA
Radiation Therapy